Date of Award


Document Type

Scholarly Project

Degree Name

Master of Physical Therapy (MPT)


Physical Therapy

First Advisor

Peggy Mohr


Baclofen; Cerebral Palsy -- drug therapy


Cerebral palsy is one of the leading developmental disabilities amongst children. The majority of children with cerebral palsy experience some degree of spasticity. This spasticity can be very painful and disabling to the child. It can affect their posture, movements, and their mobility.

Currently, baclofen is one of the most common medications used for the treatment of cerebral spasticity. It can be administered either orally or intrathecally through an implanted pump.

The purpose of this literature review is to discuss the use of oral and intrathecal baclofen in the management of spasticity in children with cerebral palsy. Included is a discussion about cerebral palsy and the spasticity that accompanies it. Also included is a discussion about the physical therapy that is provided to enhance baclofen therapy.